![Yi Shan Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Shan Li
Gründer bei
BLOSSOMHILL THERAPEUTICS, INC.
Profil
Dr. Yi Shan Li is an Executive Chairman at Blossomhill Therapeutics, Inc. Dr. Li was previously employed as a Head-TP Therapeutics Asia by Turning Point Therapeutics, Inc., an Executive Vice President by Epitomics, Inc., a Vice President by Kenson Ventures LLC, a Principal by RBC Capital Markets LLC, a Principal by Santa Cruz Biotechnology, Inc., and a Member by University of California, Berkeley.
He also served on the board at SABiosciences Corp.
He received his undergraduate degree from the University of Science & Technology of China, an MBA from the University of California, Berkeley and a doctorate degree from The Ohio State University.
Aktive Positionen von Yi Shan Li
| Unternehmen | Position | Beginn |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Gründer | 01.06.2020 |
Ehemalige bekannte Positionen von Yi Shan Li
| Unternehmen | Position | Ende |
|---|---|---|
| TURG POIN | Vorstandsvorsitzender | 01.09.2018 |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Corporate Officer/Principal | 30.04.2013 |
SABiosciences Corp.
 SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Direktor/Vorstandsmitglied | 31.12.2009 |
Kenson Ventures LLC
 Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Private Equity Investor | 31.12.2003 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Ausbildung von Yi Shan Li
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kenson Ventures LLC
Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Finance |
Santa Cruz Biotechnology, Inc.
 Santa Cruz Biotechnology, Inc. BiotechnologyHealth Technology Provides primary antibodies and support products services | Health Technology |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SABiosciences Corp.
SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
